Skip to content
Governance Register

← US public companies

Generation Bio Co.

SEC CIK 1733294 · GBIO · last insider filing 2026-02-09

Directors (from insider filings)

NameCapacity as filedFilings
Jonas Jeffrey M Director filed 2020 - 2026
Rowland Charles A Jr Director filed 2020 - 2026
Christensen Gustav Director filed 2020 - 2026
Quinn Anthony G. Director filed 2020 - 2026
Rhodes Jason P Director filed 2020 - 2026
Cooper Ronald Harold Wilfred Director filed 2021 - 2026
Stehman-Breen Catherine Director filed 2020 - 2026
Mcdonough Geoff Director · See Remarks filed 2020 - 2026
Nicholson Donald William Director filed 2020 - 2026
Appelhans Dannielle Director filed 2022 - 2026

Officers (from insider filings)

NameTitle as filedFilings
Howze Yalonda INTERIM CEO AND PRESIDENT filed 2023 - 2026
Conway Kevin John Chief Financial Officer filed 2025 - 2026
Paone Antoinette CHIEF OPERATING OFFICER filed 2022 - 2025
Samayoa Phillip CHIEF STRATEGY OFFICER filed 2022 - 2025
Stanton Matthew Chief Scientific Officer filed 2020 - 2025
Norkunas Matthew Chief Financial Officer filed 2020 - 2025
Kerr Douglas Chief Development Officer filed 2020 - 2024
Zimmermann Tracy Chief Development Officer filed 2020 - 2024
Angelino Mark D. Chief Operating Officer filed 2020 - 2021
Dipalma Stephen J. See Remarks filed 2020 - 2020

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.